Clinical Trials Browser

Phase 2 × Brain Neoplasms × sintilimab × Clear all

NCT04213170 2019-12-30

Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer

Phase 2 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung